A research team at Mahidol University in Thailand has developed a blood test that can detect clinically significant prostate cancer in high-risk patients.
According to study lead scientist Dr Sebastian Bhakdi, the test is capable of isolating and visualising tumour-associated circulating endothelial cells (tCEC) using a small, 10ml blood sample.
Bhakdi said: “Tumour-associated circulating endothelial cells are highly promising biomarkers for the detection of early-stage cancers because they are thought to derive directly from a tumour’s own blood vessels.
